Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New blood test uncovers individual risk for lung cancer

03.09.2003


Smokers carrying a newly found genetic marker are 5-10 times more likely to fall victim to the disease than other smokers; 120 times more than nonsmokers who don’t carry the marker

Scientists at the Weizmann Institute have discovered a new genetic risk factor that increases the susceptibility of smokers to lung cancer.

Published in the Journal of the National Cancer Institute, the findings show that smokers who carry the newly discovered genetic marker are around 120 times more likely to get lung cancer than non-smokers who do not have the risk factor.



A simple blood test based on these findings will be able to detect smokers who are at especially high risk of developing lung cancer.

The findings, made by Prof. Zvi Livneh and Dr. Tamar Paz-Elizur of the Biological Chemistry Department, are a result of many years of research conducted on the role of DNA-repair mechanisms in cancer. The scientists focused on lung cancer, one of the most common and most deadly cancers, responsible for 30% of all cancer deaths. In the USA alone there are 160,000 new patients per year. Smoking is the major cause of lung cancer, and 90% of hospitalized lung cancer patients are smokers. However, only 10% of heavy smokers develop the disease, suggesting involvement of a personal genetic susceptibility. Livneh struck up a collaboration with Dr. Meir Krupsky of the Chaim Sheba Medical Center to determine whether this susceptibility is caused by a decreased ability to repair DNA damage.

Our DNA is damaged about 20,000 times a day by factors such as sunlight, smoke and reactions within the body. If left unrepaired, damages to the DNA can lead to cancer. Fortunately the body has a stock of enzymes whose function is to repair DNA. These enzymes scan the DNA and detect damage using sophisticated sensor systems. Upon detection of damage, the enzymes perform an "operation" on the DNA, cutting out the damaged part and replacing it with a new DNA part. Thus the efficiency of the repair systems is critical for the prevention of cancer.

Livneh and his team concentrated on a specific DNA repair enzyme, called OGG1 (8-oxoguanine DNA glycosylase 1). This repair enzyme deletes DNA parts damaged by toxic molecules called oxygen radicals, which are found in tobacco smoke. The team developed a new blood test that enabled them to measure the level of activity of OGG1. Using this method, the researchers found that 40% of lung cancer patients have low levels of OGG1 activity, in contrast to only 4% of the general population.

These and other findings published in the study show that low OGG1 activity results in high susceptibility to cancer: 5-10 times more than those whose OGG1 activity is normal. Smoking increases this risk, since it causes more damage for DNA repair enzymes, including OGG1, to fix. Smokers who have a low level of OGG1 activity were found to have the greatest risk of lung cancer, as much as 120 higher than non-smokers with regular levels of OGG1 activity.

These findings suggest that a substantial portion of lung cancer cases might result from a combination of smoking and reduced OGG1 activity.

If so, then screening smokers for low OGG1 activity will help them make more informed decisions to stop smoking. Of course, even smokers with normal OGG1 activity are at a greater risk of getting lung cancer than the general population and the blood test will not ensure that they don’t get the disease. In addition, smoking causes other types of cancer and cardiovascular diseases, whose relation to OGG1 activity is still unknown.

The Weizmann team also included Dr. Sara Blumenstein and Dalia Elinger. Statistical analysis was conducted by Dr. Edna Schechtman from Ben-Gurion University.

Prof. Zvi Livneh’s research is supported by the Dolfi and Lola Ebner Center for BiomedicalResearch, the Levine Institute of Applied Science and the M.D. Moross Institute for Cancer Research.

Prof. Livneh is the incumbent of the Maxwell Ellis Professorial Chair in Biomedical Research.


The Weizmann Institute of Science in Rehovot, Israel is one of the world’s top-ranking multidisciplinary research institutions. Noted for its wide-ranging exploration of the natural and exact sciences, the Institute is home to 2,500 scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.

Alex Smith | EurekAlert!
Further information:
http://www.weizmann.ac.il/

More articles from Health and Medicine:

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Massive impact crater from a kilometer-wide iron meteorite discovered in Greenland

15.11.2018 | Earth Sciences

When electric fields make spins swirl

15.11.2018 | Physics and Astronomy

Discovery of a cool super-Earth

15.11.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>